DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Dado Ruvic - 1 GitLab - 1 Koji Ikeda - 1 Chibuike Oguh - 1 Lance Tupper - 1 Richard Chang - 1
Top related locs:
New York
Top related orgs:
Intelligence - 1 REUTERS - 1 GitLab Inc - 1 " Bank of America - 1 Thomson - 1

Search resuls for: "GitLab Inc"


2 mentions found


☆ GitLab soars on plan for new AI-powered product
  + stars: | 2023-06-06 | by ( Chibuike Oguh | Thomson Reuters | Chibuike Reports On Mostly Large U.S.-Based Private Equity Firms | ) www.reuters.com   time to read: +1 min
[1/2] GitLab Inc logo and words 'Artificial Intelligence' are seen in this illustration taken June 6, 2023. REUTERS/Dado Ruvic/IllustrationNEW YORK, June 6 (Reuters) - Shares of GitLab Inc (GTLB.O) jumped more than 35% on Tuesday after the software development platform announced plans to launch a revenue-boosting artificial intelligence (AI)-powered product. The product is expected to be launched this year at $9 per month, GitLab said late Monday. GitLab said on Monday its first-quarter revenue jumped 45% to $126.9 million, beating the Refinitiv consensus estimate and the company's earlier forecasts. Eighteen analysts on average recommended buying GitLab shares, and set a median price target of $53.50, according to Refinitiv.
Persons: Dado Ruvic, GitLab, Koji Ikeda, Chibuike Oguh, Lance Tupper, Richard Chang Organizations: Intelligence, REUTERS, GitLab Inc, " Bank of America, Thomson Locations: New York
☆ These are the top 10 stock plays for 2023, according to UBS
  + stars: | 2022-12-14 | by ( Carmen Reinicke | ) www.cnbc.com   time to read: +5 min
As the year winds down, investors are looking forward to 2023 and wondering where they should place their top bets. Analysts that cover companies are mulling the same question, prompting UBS to put together a list of its top conviction picks for 2023. The stock which is poised for the largest gain is Kymera Therapeutics , a biotechnology firm that UBS thinks could surge 240% to its target price. She added that UBS expects updates across all four programs in the near term as well as over 2023. Analysts that cover companies are mulling the same question, prompting UBS to put together a list of its top conviction picks for 2023.
0 next >>
Total: 2